| MERCK KGAA O.N. | 143.05 / +1.38% |
| Date/Time | 01/25 / 17:35 |
| Chg. / Chg.(%) | 1.95 / +1.38% |
| Bid | - |
| Ask | - |
| Open | 142.55 |
| Previous Close | 141.10 |
| High | 143.70 |
| Low | 141.00 |
| Volume [EUR] | 58,022,667.45 |
| Volume [Units] | 406,790 |
| Price fixings | 3535 |
| ISIN | DE0006599905 |
| Security | MRK |
| Exchange | Xetra |
| Type | Stock |
| Bid Size | Bid | Ask | Ask size |
|---|---|---|---|
| 141 | 142.90 | 143.05 | 208 |
| 146 | 142.85 | - | - |
| 168 | 142.80 | - | - |
| 93 | 142.75 | - | - |
| 964 | 142.70 | - | - |
| 89 | 142.65 | - | - |
| 913 | 142.60 | - | - |
| 2,732 | 142.55 | - | - |
| 796 | 142.50 | - | - |
| 2,444 | 142.45 | - | - |
News
- Advaxis Reports Fiscal Year 2020 Financial Results and Provides a Business Update
13:00 - GlobeNewswire - Cocrystal Pharma Announces Further Development of Influenza A/B Antiviral Compounds by Merck under Exclusive Worldwide License and Collaboration Agreement
01/19/2021 / 14:00 - GlobeNewswire - Merck, US gov't sign COVID therapeutic supply deal
12/23/2020 / 14:14 - TeleTrader - Merck divests direct holding in Moderna
12/02/2020 / 13:19 - TeleTrader - Merck to buy COVID therapy candidate maker OncoImmune
11/23/2020 / 13:09 - TeleTrader
Real-time